Trials / Completed
CompletedNCT02105818
Swallowing Difficulties With Medication Intake and Coping Strategies in Patients With Systemic Sclerosis
Swallowing Difficulties With Medication Intake and Coping Strategies in Patients With Systemic Sclerosis: a Cross-sectional Cohort Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 64 (actual)
- Sponsor
- Kurt Hersberger · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is the validation of a newly developed self-report questionnaire which aims at determining the prevalence, location and intensity of SWAllowing difficulties with drug intake, and describing the impact on MEdication regimen focusing on COping strategies (SWAMECO).
Detailed description
The study aims at investigating a cohort of patients with diagnosed systemic sclerosis using the newly developed self-report SWAMECO-questionnaire. The self-report questionnaire is sub-divided into four sections: detection of swallowing difficulties, coping strategies, risk factors to develop swallowing difficulties and adherence to medication. This study involves patients with systemic sclerosis. Systemic sclerosis often is accompanied by swallowing disorders which may lead to issues in handling medication regimen with risks for patient safety.
Conditions
- Systemic Sclerosis
- Deglutition Disorders
- Adherence to Medication Regime
- Coping Behaviour
- Scleroderma, Systemic
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2014-06-01
- Completion
- 2014-07-01
- First posted
- 2014-04-07
- Last updated
- 2017-04-13
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT02105818. Inclusion in this directory is not an endorsement.